Boundless Bio (BOLD) shares surge over 95% premarket after the company and and Serapha Bio entered into a definitive all-stock merger agreement. Following the transaction, the combined company will ...

The transaction marks the latest turn in the fortunes of Passage Bio, one of the companies started by gene therapy pioneer ...

A new gene-editing startup negotiated contracts with a Chinese company, raised $230 million in funding, and executed a ...

University of Pennsylvania spinout Passage Bio has found a merger partner after four rounds of layoffs in as many years left ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”) , a biotechnology company developing next-generation cell and gene therapies using ...

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, ...

REDWOOD CITY, Calif., December 26, 2025--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...

PHILADELPHIA, July 10, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. ("Passage Bio” or the "Company”) (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients ...

LA JOLLA, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T ("NKT") cell ...